Santhera Pharmaceuticals SPHDF Stock
Santhera Pharmaceuticals Price Chart
Santhera Pharmaceuticals SPHDF Financial and Trading Overview
| Santhera Pharmaceuticals stock price | 18.3 USD |
| Previous Close | 18.3 USD |
| Open | 22.85 USD |
| Bid | 22.7 USD x 10000 |
| Ask | 24.75 USD x 10000 |
| Day's Range | 22.85 - 22.85 USD |
| 52 Week Range | 12.28 - 23.25 USD |
| Volume | 100 USD |
| Avg. Volume | 10 USD |
| Market Cap | 280.34M USD |
| Beta (5Y Monthly) | -0.393 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.82 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SPHDF Valuation Measures
| Enterprise Value | 274.07M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.76194 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.7 |
| Enterprise Value/EBITDA | -75.357 |
Trading Information
Santhera Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.393 |
| 52-Week Change | 49.08% |
| S&P500 52-Week Change | 15.11% |
| 52 Week High | 23.25 USD |
| 52 Week Low | 12.28 USD |
| 50-Day Moving Average | 20.56 USD |
| 200-Day Moving Average | 20.73 USD |
SPHDF Share Statistics
| Avg. Volume (3 month) | 10 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 15.32M |
| Float | 12.63M |
| Short Ratio | N/A |
| % Held by Insiders | 11.15% |
| % Held by Institutions | 16.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -31.45% |
| Operating Margin (ttm) | -13.58% |
| Gross Margin | 40.98% |
| EBITDA Margin | -3.58% |
Management Effectiveness
| Return on Assets (ttm) | -3.92% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 101.5M USD |
| Revenue Per Share (ttm) | 7.36 USD |
| Quarterly Revenue Growth (yoy) | 101.29% |
| Gross Profit (ttm) | 41.6M USD |
| EBITDA | -3637000 USD |
| Net Income Avi to Common (ttm) | -31930000 USD |
| Diluted EPS (ttm) | -2.82 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.77M USD |
| Total Cash Per Share (mrq) | 2.78 USD |
| Total Debt (mrq) | 41.28M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.729 |
| Book Value Per Share (mrq) | -0.4900805 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 660K USD |
| Levered Free Cash Flow (ttm) | -21159250 USD |
Profile of Santhera Pharmaceuticals
| Country | United States |
| State | N/A |
| City | Pratteln |
| Address | Hohenrainstrasse 24 |
| ZIP | 4133 |
| Phone | 41 61 906 89 50 |
| Website | https://www.santhera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 93 |
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Q&A For Santhera Pharmaceuticals Stock
What is a current SPHDF stock price?
Santhera Pharmaceuticals SPHDF stock price today per share is 18.3 USD.
How to purchase Santhera Pharmaceuticals stock?
You can buy SPHDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Santhera Pharmaceuticals?
The stock symbol or ticker of Santhera Pharmaceuticals is SPHDF.
Which industry does the Santhera Pharmaceuticals company belong to?
The Santhera Pharmaceuticals industry is Biotechnology.
How many shares does Santhera Pharmaceuticals have in circulation?
The max supply of Santhera Pharmaceuticals shares is 15.32M.
What is Santhera Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Santhera Pharmaceuticals PE Ratio is now.
What was Santhera Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Santhera Pharmaceuticals EPS is -2.82 USD over the trailing 12 months.
Which sector does the Santhera Pharmaceuticals company belong to?
The Santhera Pharmaceuticals sector is Healthcare.
